Market Tracker

07/28 4:19pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

3.56
Delayed Data
As of 4:00pm ET
 -0.01 / -0.28%
Today’s Change
2.58
Today|||52-Week Range
6.11
+0.56%
Year-to-Date
3 High-Yield Dividend Stocks You Should Avoid
Jul 24 / MotleyFool.com - Paid Partner Content
The 3 Most Dangerous High-Yield Dividend Stocks
Jul 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.57
Today’s open3.53
Day’s range3.52 - 3.59
Volume509,556
Average volume (3 months)1,403,477
Market cap$589.5M
Dividend yield5.62%
Data as of 4:00pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-73.76%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio1.9
Price/Sales0.99
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.12-1.16%
DVAXDynavax Technologies...-0.31-1.96%
CLVSClovis Oncology Inc-0.46-3.17%
ARRYArray Biopharma Inc-0.09-2.33%
Data as of 4:00pm ET, 07/28/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts